Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

3917 results

Sort By:

A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema

Study ID: NCT06807281
Start Date: 2025-11-03
End Date: 2032-02-22
Study Type

Interventional

Study Phase

Phase3

No. of Participants

500

Intervention / Treatment

Abrocitinib

Sponsor

Pfizer

Source: clinicaltrials.gov

Share:
Add to list

PREDICT-RD: ctDNA Surveillance in TNBC With Residual Disease

Study ID: NCT07069595
Start Date: 2025-09
End Date: 2028-11
Study Type

Interventional

Study Phase

Phase2

No. of Participants

78

Intervention / Treatment

Datopotamab deruxtecan

Circulating tumor DNA (ctDNA) testing

Sponsor

UNC Lineberger Comprehensive Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Neuromodulation and FMRI in Neurodegenerative Diseases Study

Study ID: NCT06873750
Start Date: 2025-09-01
End Date: 2027-12-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

Transcranial Alternating Current Stimulation

Sponsor

Sunnybrook Health Sciences Centre

Source: clinicaltrials.gov

Share:
Add to list

Testing the Anti-cancer Drug, Glofitamab, in Patients With Mantle Cell Lymphoma (A Type of Blood Cancer) Whose Disease Returned After CAR-T Cell Therapy

Study ID: NCT07003295
Start Date: 2025-10-31
End Date: 2027-08-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

20

Intervention / Treatment

Biospecimen Collection

Computed Tomography

Glofitamab

Obinutuzumab

Positron Emission Tomography

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Food and Fitness With Medicine (FFWM)

Study ID: NCT07027995
Start Date: 2025-09
End Date: 2029-03
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

Exercise is Medicine (EIM)

Culinary Education

Food is Medicine

Nutrition Counseling

Participant Website

Sponsor

Ohio State University

Source: clinicaltrials.gov

Share:
Add to list

The CCANED-CIPHER Study: Early Cancer Detection and Treatment Response Monitoring Using AI-Based Platelet and Immune Cell Transcriptomic Profiling

Study ID: NCT06717295
Start Date: 2025-08-01
End Date: 2028-08-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

6000

Intervention / Treatment

DiNanoQ: A multi-cancer early detection (MCED) blood test

DiNanoTrack: Therapeutic Response Monitoring Blood Test

Sponsor

Javier Toledo

Source: clinicaltrials.gov

Share:
Add to list

Adapting Changing Talk: Online (CHATO) to CHATO-Inclusive

Study ID: NCT06636214
Start Date: 2026-08-31
End Date: 2029-07-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

1200

Intervention / Treatment

Boring

Sponsor

University of Kansas Medical Center

Source: clinicaltrials.gov

Share:
Add to list

Liver Biopsy Following Gene Therapy For Hemophilia

Study ID: NCT05932914
Start Date: 2025-08
End Date: 2026-05
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

8

Intervention / Treatment

Liver Biopsy

Sponsor

St. Jude Children's Research Hospital

Source: clinicaltrials.gov

Share:
Add to list

Pegmolesatide Treatment for Anemia in Patients Undergoing Long-term Dialysis

Study ID: NCT07045155
Start Date: 2025-08-01
End Date: 2028-12-30
Study Type

Interventional

Study Phase

Phase4

No. of Participants

240

Intervention / Treatment

The rHuEPO Monotherapy Group (Control Group)

The Pegmolesatide and Roxadustat Combination Therapy Group (Exploratory Group)

The Pegmolesatide Monotherapy Group (Experimental group)

Sponsor

Chinese PLA General Hospital

Source: clinicaltrials.gov

Share:
Add to list

Safety and Effectiveness of Left Bundle Branch Area Pacing Versus Conventional Cardiac Resynchronization Therapy in Heart Failure

Study ID: NCT07069738
Start Date: 2025-10
End Date: 2029-11
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

850

Intervention / Treatment

CRT-D with a Quadripolar LV lead

CRT-D with INGEVITY+ pace/sense lead

Sponsor

Boston Scientific Corporation

Source: clinicaltrials.gov

Share:
Add to list